China&rsꦛquo;s healthcare sector kept growing over the second quarter of 2019. The period was characterised by increased government spending on healthcare, with the amount dedicated to health and family plan💙ning rising by 5.9% y/y to RMB 534.5bn in Q2 ...

The first quarter of 2019 witnessed a continuous growth of China’s healthcare sector. The country promoted the implementation of the Healthy China Initiative, as well as ongoing structural reforms in th♎e sector. The period was characterized by ...

China’s healthcare sector continued to grow in Q4 2018, largely stimulated by the expansion of online healthcare service💜s. The ✃growth was attributed to increasing demand for quality healthcare, driven by the country’s strong economic ...

China is the world’s second largest pharmaceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world&rsquo🙈;s most populous country, with a large share of ageing ...

With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of China ♛being more than twice that ...

In the third quarter of 2018, China’s pharmaceutical and medicine production declined by 28.5% y/y to 573,000 tonnes, In 2018, many pharmaceutical producers were affected by🦄 the ongoing reform for new chemical drugs classification system, and ...

The third quarter of 2018 witnessed a continuous growth of China’s healthcare 🏅sector, mostly driven by the online healthcare segment. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s 🌸...

In the second quarter of 2018, China’s pharmaceutical and medicine production declined by 21.1% y/y to 749,000 tonn🌟es, while their sales volume dropped by 22.7% y/y to 753,000 tonnes. This can be linked with the more 🌠stringent environmental ...

The second quarter of 2018 witnessed a𝔉 continuous growth of China’s healthcare sector. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s strong economic performance, rising incomes, ...

The first quarter of 2018 witnessed a continuous growth of Chinꦑa’s healthcare sector, stimulated by government policies and regulations. The country’s total spending on health and family planning reached RMB 442.6bn, up by 7.8% ...